help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on January 16, 2009, doi:10.1165/rcmb.2008-0307OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2008-0307OCv1
41/3/290    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Kohan, M.
Right arrow Articles by Berkman, N.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kohan, M.
Right arrow Articles by Berkman, N.
American Journal of Respiratory Cell and Molecular Biology. Vol. 41, pp. 290-296, 2009
© 2009 American Thoracic Society
DOI: 10.1165/rcmb.2008-0307OC

Osteopontin Induces Airway Remodeling and Lung Fibroblast Activation in a Murine Model of Asthma

Martin Kohan1, Raphael Breuer1 and Neville Berkman1

1 Lung Cellular and Molecular Biology Laboratory, Institute of Pulmonology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

Correspondence and requests for reprints should be addressed to Neville Berkman, MBBCh, FRCP, Institute of Pulmonology, Hadassah-Hebrew University Medical Center, POB 12000, Jerusalem, Israel 91120. E-mail: Neville{at}hadassah.org.il

Airway remodeling is a central feature of asthma; however, the mechanisms underlying its development have not been fully elucidated. We have demonstrated that osteopontin, an inflammatory cytokine and an extracellular matrix glycoprotein with profibrotic properties, is up-regulated in a murine model of allergen-induced airway remodeling. In the present study, we determined whether osteopontin plays a functional role in airway remodeling. Osteopontin (OPN)-deficient (OPN–/–) and wild-type mice were sensitized and exposed to inhaled ovalbumin (OVA) or saline for 5 weeks. Collagen production, peribronchial smooth muscle area, mucus-producing cell number, and bronchoalveolar cell counts were assessed. The functional behavior and phenotype of lung fibroblasts from OVA-treated OPN–/– and from wild-type mice were studied using ex vivo cultures. OVA-treated OPN–/– mice exhibited reduced lung collagen content, smooth muscle area, mucus-producing cells, and inflammatory cell accumulation as compared with wild-type mice. Reduced matrix metalloproteinase-2 activity and expression of transforming growth factor-β1 and vascular endothelial growth factor were observed in OVA-treated OPN–/– mice. Lung fibroblasts from OVA-treated OPN–/– mice showed reduced proliferation, migration, collagen deposition, and {alpha}–smooth muscle actin expression in comparison with OVA-treated wild-type lung fibroblasts. Thus, OPN is key for the development of allergen-induced airway remodeling in mice. In response to allergen, OPN induces the switching of lung fibroblasts to a pro-fibrogenic myofibroblast phenotype.

Key Words: airway remodeling • fibroblast • mouse model • myofibroblast • osteopontin







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2009 American Thoracic Society.
  SOTA, FL